PTPI Petros Pharmaceuticals, Inc.

Fundamentals / CIK 0001815903 / USD

Petros Pharmaceuticals, Inc. reported $3.55M in total assets and a net loss of $3.20M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PTPI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$11.60M$5.80M$0-$20.06MFY 2020 Revenue: $9.56MFY 2020 Net Income: -$20.59M2020FY 2021 Revenue: $7.81MFY 2021 Net Income: -$8.99M2021FY 2022 Revenue: $5.99MFY 2022 Net Income: -$20.04M2022FY 2023 Revenue: $5.82MFY 2023 Net Income: -$8.16M2023FY 2024 Revenue: $5.11MFY 2024 Net Income: -$14.32M2024FY 2025 Net Income: $1.91M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- $5.11M $5.82M $5.99M $7.81M $9.56M
Cost of Revenue -- $1.21M $1.63M $2.29M $1.60M $4.05M
Gross Profit -- $3.90M $4.19M $3.70M $6.21M $5.51M
Research & Development -- $2.62M $2.41M $1.74M $1.79M $460K
Selling, General & Admin $4.64M $4.63M $9.26M $12.21M $15.59M $15.67M
Total Operating Expenses $4.64M $4.63M $17.81M $23.62M $24.26M $22.80M
Operating Income -$4.64M -$4.63M -$13.62M -$19.92M -$18.05M -$17.28M
EBITDA -- -$1.80M -$10.33M -$14.32M -$11.17M -$10.62M
Interest Income -- $372K $515K $14K -- --
Interest Expense -- $561K $536K $596K $369K $3.05M
Income Before Tax -$4.50M -$705K -$8.16M -$20.04M -$8.99M -$22.01M
Income Tax Expense $0 $0 $0 -- $0 -$1.43M
Net Income $1.91M -$14.32M -$8.16M -$20.04M -$8.99M -$20.59M
Basic EPS -$1.56 -$83.47 -$158.75 -$242.00 -$206.25 -$962.50
Diluted EPS -$1.56 -$83.47 -$158.75 -$242.00 -$206.25 -$962.50
Basic Shares Outstanding 28.1M 321.0K 87.0K 82.8K 43.6K 21.4K
Diluted Shares Outstanding 28.1M 321.0K 87.0K 82.8K 43.6K 21.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue -- -- -- -- -- -- $725K $1.58M
Cost of Revenue -- -- -- -- -- -- $265K $287K
Gross Profit -- -- -- -- -- -- $461K $1.29M
Research & Development -- -- -- -- -- -- $102K $588K
Selling, General & Admin $989K $1.03M $391K $991K $1.80M $1.46M $578K $1.20M
Total Operating Expenses $989K $1.03M $391K $991K $1.80M $1.46M $578K $1.20M
Operating Income -$989K -$1.03M -$391K -$991K -$1.80M -$1.46M -$578K -$1.20M
EBITDA -- -- -- -- -- -- $79K -$458K
Interest Income -- -- -- -- -- -- $25K $76K
Income Before Tax -$956K -$987K -$337K -$923K -$2.04M -$1.20M -$553K -$920K
Net Income -$956K -$987K -$337K -$923K $5.43M -$2.26M -$9.27M -$2.22M
Basic EPS -$0.30 -$0.03 -- -$0.03 -$1.20 -$9.37 -- -$16.65
Diluted EPS -$0.30 -$0.03 -- -$0.03 -$1.20 -$9.37 -- -$16.65
Basic Shares Outstanding 47.4M 46.2M -- 42.3M 25.9M 1.2M -- 393.2K
Diluted Shares Outstanding 47.4M 46.2M -- 42.3M 25.9M 1.2M -- 393.2K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $5.14M $1.72M $13.34M $9.43M $23.85M $17.14M
Cash & Short-Term Investments $5.14M $1.72M $13.34M $9.43M $23.85M $17.14M
Accounts Receivable, Net -- $416K $2.23M $2.11M $2.46M $5.15M
Inventory -- $1.35M $1.61M $1.82M $520K $761K
Other Current Assets -- $6.5K $111K $138K $110K $115K
Total Current Assets $5.16M $7.29M $20.39M $14.67M $30.54M $25.91M
Property, Plant & Equipment, Net -- $23K $29K $39K $49K $64K
Intangible Assets -- $3.20M $8.97M $12.24M $25.29M $32.16M
Other Non-Current Assets -- -- -- $358K $476K $580K
Total Non-Current Assets $0 $3.34M $13.41M $17.75M $36.85M $43.95M
Total Assets $5.16M $10.64M $33.80M $32.42M $67.39M $69.85M
Accounts Payable $84K $764K $1.71M $1.81M $4.56M $5.61M
Short-Term Debt -- -- -- -- -- $7.18M
Other Current Liabilities -- $78K $493K $537K $261K $222K
Total Current Liabilities $2.29M $18.03M $10.77M $7.07M $30.98M $41.89M
Other Non-Current Liabilities -- $75K $138K $263K $405K $601K
Total Non-Current Liabilities $0 $75K $10.55M $8.65M $865K $10.49M
Total Liabilities $2.29M $18.10M $21.32M $15.72M $31.85M $52.38M
Total Debt (incl. Leases) -- $138K $263K $405K $531K $7.81M
Common Stock $4.2K $42 $298 $208 $207 $971
Retained Earnings -$111.3M -$113.2M -$98.89M -$90.73M -$70.69M -$61.70M
Total Stockholders' Equity $2.87M -$7.47M $12.07M $16.70M $35.54M $17.47M
Total Equity $2.87M -$7.47M $12.07M $16.70M $35.54M $17.47M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $3.49M $4.35M $5.14M $6.07M $7.32M $8.93M $1.72M $3.90M
Cash & Short-Term Investments $3.49M $4.35M $5.14M $6.07M $7.32M $8.93M $1.72M $3.90M
Accounts Receivable, Net -- -- -- -- -- -- $416K $1.95M
Inventory -- -- -- -- -- -- $1.35M $1.41M
Other Current Assets -- -- -- -- -- -- $6.5K $4.8K
Total Current Assets $3.55M $4.39M $5.16M $6.13M $7.40M $14.47M $7.29M $10.72M
Property, Plant & Equipment, Net -- -- -- -- -- -- $23K $19K
Intangible Assets -- -- -- -- -- -- $3.20M $6.83M
Total Non-Current Assets $0 $0 $0 $0 $0 $3.14M $3.34M $9.97M
Total Assets $3.55M $4.39M $5.16M $6.13M $7.40M $17.61M $10.64M $20.69M
Accounts Payable $97K $133K $84K $421K $970K $757K $764K $1.60M
Other Current Liabilities -- -- -- -- -- -- $78K $353K
Total Current Liabilities $2.84M $2.62M $2.29M $2.77M $2.95M $27.13M $18.03M $12.56M
Other Non-Current Liabilities -- -- -- -- -- -- $75K $92K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $58K $75K $5.01M
Total Liabilities $2.84M $2.62M $2.29M $2.77M $2.95M $27.19M $18.10M $17.58M
Total Debt (incl. Leases) -- -- -- -- -- -- $138K --
Common Stock $4.2K $4.2K $4.2K $4.2K $4.2K $205 $42 $1.0K
Retained Earnings -$113.2M -$112.3M -$111.3M -$111.0M -$110.0M -$115.5M -$113.2M -$103.9M
Total Stockholders' Equity $701K $1.77M $2.87M $3.37M $4.45M -$9.58M -$7.47M $3.12M
Total Equity $701K $1.77M $2.87M $3.37M $4.45M -$9.58M -$7.47M $3.12M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $1.91M -$14.32M -$8.16M -$20.04M -$8.99M -$20.59M
Depreciation & Amortization -- $2.83M $3.28M $5.60M $6.88M $6.66M
Stock-Based Compensation $305K $197K $417K $1.20M $1.31M --
Change in Receivables -- $1.82M -$144K $516K $2.55M -$2.75M
Change in Inventory -- $308K $274K -$835K $413K $728K
Change in Payables -$680K $352K -$93K -$2.75M -$1.05M $2.22M
Operating Cash Flow -$6.73M -$2.60M -$7.63M -$12.80M -$11.86M -$15.31M
Capital Expenditure -- -$25K -- -- -- -$4.6K
Free Cash Flow -- -$2.63M -- -- -- -$15.31M
Investing Cash Flow -- -$25K -- -- -- -$4.6K
Common Stock Issued $9.60M -- -- -- $21.75M --
Financing Cash Flow $8.16M -$7.00M $11.54M -$1.62M $18.57M $30.30M
Net Change in Cash $1.43M -$9.63M $3.91M -$14.42M $6.71M $14.99M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$956K -$987K -$337K -$923K $5.43M -$2.26M -$9.27M -$2.22M
Depreciation & Amortization -- -- -- -- -- -- $656K $739K
Stock-Based Compensation $118K $120K -- -- $74K $80K $0 $0
Change in Receivables -- -- -- -- -- -- $1.56M -$214K
Change in Inventory -- -- -- -- -- -- $68K $71K
Change in Payables -$36K $49K -$337K -$549K $417K -$212K $420K $144K
Operating Cash Flow -$864K -$784K -$934K -$1.13M -$3.01M -$1.66M $965K -$771K
Common Stock Issued -- -- $0 $0 $0 $9.60M -- --
Financing Cash Flow -- -- $0 -$117K -$428K $8.71M -$1.14M -$2.77M
Net Change in Cash -$864K -$784K -$934K -$1.25M -$3.44M $7.05M -$185K -$3.57M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- 76.3% 72.0% 61.8% 79.5% 57.7%
Operating Margin -- -90.5% -233.9% -332.4% -231.1% -180.8%
Net Profit Margin -- -280.1% -140.2% -334.4% -115.0% -215.3%
Return on Equity (ROE) 66.7% -- -67.6% -120.0% -25.3% -117.8%
Return on Assets (ROA) 37.1% -134.6% -24.2% -61.8% -13.3% -29.5%
Current Ratio 2.25x 0.40x 1.89x 2.08x 0.99x 0.62x
Quick Ratio 2.24x 0.33x 1.74x 1.82x 0.97x 0.60x
Debt to Equity -- -- 0.02x 0.02x 0.01x 0.45x
Revenue Growth (YoY) -- -12.2% -2.8% -23.3% -18.3% --
Gross Profit Growth (YoY) -- -7.0% +13.2% -40.4% +12.7% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Gross Margin -- -- -- -- -- -- 76.3% 72.5%
Operating Margin -- -- -- -- -- -- -90.5% -225.9%
Net Profit Margin -- -- -- -- -- -- -280.1% -117.5%
Return on Equity (ROE) -456.8% 179.9% 66.7% -208.5% -187.1% -- -- -151.7%
Return on Assets (ROA) -90.3% 72.5% 37.1% -114.5% -112.5% -81.9% -134.6% -22.8%
Current Ratio 1.25x 1.68x 2.25x 2.22x 2.51x 0.53x 0.40x 0.85x
Quick Ratio 1.23x 1.66x 2.24x 2.20x 2.48x 0.33x 0.33x 0.74x
Revenue Growth (YoY) -- -- -- -- -- -- -- -5.9%
Gross Profit Growth (YoY) -- -- -- -- -- -- -- +1.8%
Net Income Growth (YoY) -117.6% -- -- -- -- -- -3014.8% --
Operating Cash Flow Growth (YoY) -- -- -196.7% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001815903) · from March 31, 2020 Data through June 30, 2026 · synced Nov 21, 2026, 05:15 UTC · Open in terminal